1. Home
  2. CFFI vs OABI Comparison

CFFI vs OABI Comparison

Compare CFFI & OABI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CFFI

C&F Financial Corporation

HOLD

Current Price

$89.44

Market Cap

253.8M

Sector

Finance

ML Signal

HOLD

Logo OmniAb Inc.

OABI

OmniAb Inc.

HOLD

Current Price

$4.66

Market Cap

294.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CFFI
OABI
Founded
1927
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
253.8M
294.3M
IPO Year
1996
2021

Fundamental Metrics

Financial Performance
Metric
CFFI
OABI
Price
$89.44
$4.66
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$4.50
AVG Volume (30 Days)
23.7K
1.6M
Earning Date
04-23-2026
05-07-2026
Dividend Yield
2.53%
N/A
EPS Growth
37.94
6.56
EPS
4.71
N/A
Revenue
$140,841,000.00
$18,666,000.00
Revenue This Year
N/A
$52.42
Revenue Next Year
N/A
$64.69
P/E Ratio
$18.47
N/A
Revenue Growth
10.63
N/A
52 Week Low
$65.39
$1.32
52 Week High
$92.00
$4.74

Technical Indicators

Market Signals
Indicator
CFFI
OABI
Relative Strength Index (RSI) 58.56 91.50
Support Level $68.76 $1.69
Resistance Level $90.88 N/A
Average True Range (ATR) 2.59 0.36
MACD -0.18 0.17
Stochastic Oscillator 56.59 99.63

Price Performance

Historical Comparison
CFFI
OABI

About CFFI C&F Financial Corporation

C&F Financial Corp is an American bank holding company. The company through its subsidiaries offers banking and related financial services to both individuals and businesses. It operates in three business activities: Community Banking, Mortgage Banking, and Consumer Finance. It mainly provides a range of lending activities, which include residential mortgage loans, commercial real estate loans, non-prime automobile lending, land acquisition, and development loans, and consumer loans. The company generates maximum of its revenue from the Community Banking segment.

About OABI OmniAb Inc.

OmniAb Inc licenses discovery research technology to pharmaceutical and biotech companies and academic institutions to enable the discovery of next-generation therapeutics. Its technology platform creates and screens diverse antibody repertoires and is designed to quickly identify optimal antibodies and other target-binding proteins for its partners' drug development efforts. At the heart of the OmniAb platform is what it calls Biological Intelligence, which powers the immune systems of proprietary, engineered transgenic animals to create optimized antibody candidates for human therapeutics.

Share on Social Networks: